These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28815989)

  • 1. Can we improve risk communication about non-invasive prenatal testing?
    Petrova D; Garcia-Retamero R
    BJOG; 2018 Feb; 125(3):272-276. PubMed ID: 28815989
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome.
    Kou KO; Poon CF; Kwok SL; Chan KY; Tang MH; Kan AS; Leung KY
    Hong Kong Med J; 2016 Jun; 22(3):223-30. PubMed ID: 27149976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Mosimann B
    Ther Umsch; 2016; 73(7):398-403. PubMed ID: 27998249
    [No Abstract]   [Full Text] [Related]  

  • 5. What are the goals of prenatal genetic testing?
    Dukhovny S; Norton ME
    Semin Perinatol; 2018 Aug; 42(5):270-274. PubMed ID: 30195989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening.
    Eastgate G; Lennox N
    Aust Fam Physician; 2003 Jun; 32(6):394; author reply 394. PubMed ID: 12833758
    [No Abstract]   [Full Text] [Related]  

  • 7. A questionnaire study of women's views regarding the effectiveness of serum Down screening in north west Wales.
    Bulman J; Nan A; Markland MH; Al-Safi W; Leeson S
    J Obstet Gynaecol; 2004 Jan; 24(1):33-9. PubMed ID: 14675978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the current dilemma of Down syndrome screening.
    Rose NC
    Obstet Gynecol; 2006 Jan; 107(1):2-3. PubMed ID: 16394031
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical utility and cost of non-invasive prenatal testing.
    Cuckle H; Benn P; Pergament E
    J Matern Fetal Neonatal Med; 2014 Feb; 27(3):320-1. PubMed ID: 23875873
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly.
    Benn P; Cuckle H; Pergament E
    Ultrasound Obstet Gynecol; 2012 Feb; 39(2):127-30. PubMed ID: 22278776
    [No Abstract]   [Full Text] [Related]  

  • 11. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice.
    Salomon LJ; Alfirevic Z; Audibert F; Kagan KO; Paladini D; Yeo G; Raine-Fenning N;
    Ultrasound Obstet Gynecol; 2014 Jul; 44(1):122-3. PubMed ID: 24895295
    [No Abstract]   [Full Text] [Related]  

  • 13. Low MSAFP and new biochemical markers for Down syndrome: implications for genetic counselors.
    Kloza EM
    Birth Defects Orig Artic Ser; 1990; 26(3):31-43. PubMed ID: 1709365
    [No Abstract]   [Full Text] [Related]  

  • 14. A 35-year-old pregnant woman considering maternal serum screening and amniocentesis.
    Mennuti M
    JAMA; 1996 May; 275(18):1440-6. PubMed ID: 8618372
    [No Abstract]   [Full Text] [Related]  

  • 15. Counseling and screening for chromosomal abnormalities.
    Kahn KR; Bett GC
    Am J Obstet Gynecol; 2010 Mar; 202(3):e13; author reply e13. PubMed ID: 20004883
    [No Abstract]   [Full Text] [Related]  

  • 16. Counseling for non-invasive prenatal testing (NIPT): what pregnant women may want to know.
    Oepkes D; Yaron Y; Kozlowski P; Rego de Sousa MJ; Bartha JL; van den Akker ES; Dornan SM; Krampl-Bettelheim E; Schmid M; Wielgos M; Cirigliano V; Di Renzo GC; Cameron A; Calda P; Tabor A
    Ultrasound Obstet Gynecol; 2014 Jul; 44(1):1-5. PubMed ID: 24984969
    [No Abstract]   [Full Text] [Related]  

  • 17. Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing.
    Lindquist A; Poulton A; Halliday J; Hui L
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):487-492. PubMed ID: 29226487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
    Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
    Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential pathways of testing after first-trimester screening for trisomy 21.
    Malone FD
    Obstet Gynecol; 2005 Feb; 105(2):438; author reply 438-9. PubMed ID: 15684179
    [No Abstract]   [Full Text] [Related]  

  • 20. Anomalous marker patterns in Down syndrome screening.
    Wald NJ; Bestwick JP; Barnes IM; Kellner LH
    Prenat Diagn; 2007 Feb; 27(2):185-6. PubMed ID: 17266168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.